Services

portfolio-2b

Educational Campaigns

  • General Introduction to Regulated Medical Cannabis
  • “Eligibility Qualifications Manual” to assist physicians in qualifying a patient –  ICD-10 Codes Utilized.Manual available in print and web-based.
  • Printed piece and web sections on Dosing and Documentation
  • Social media & web presence answering public’s questions (“Ask Doc Cannabis”)
  • Speakers Bureau on Cannabis Science Centers Project

Professional Outreach Campaigns

Contact with Licensed Care Providers – Individually & In Groups

  • Hospitals & Health Systems
  • Certified Long Term Care Facilities
  • Home Health Agencies
  • Outpatient Oncology Centers
  • Hospice Programs
  • HIV/AIDS Services

Direct Provider Contact with Health Care Professionals – Individually & in Groups 

Those who can write recommendations (dependent on state statute & regulations)

  • Doctors of Medicine,
  • Doctors of Osteopathy
  • Licensed Physician Assistants
  • Licensed Advance Practice Registered Nurses

Prescriber support staff

  • All licensed medical specialties
  • Social Workers, Psychologists,
  • Administrators
  • Homeopathic & Naturopathic physicians and holistic treatment center staff.

Training modules will also be developed for law enforcement officers and police training academy students.

CME

When medical cannabis is made more widely available by a legal distribution system, there needs to be a comprehensive continuing medical education program for health care professionals. Cannabis Science Centers will develop and deliver evidence-based continuing education programing on medicinal marijuana and its use in a health care setting — a health care topic in high demand but where virtually no such programs exist.

Plan first educational components:

  • Introduction to Cannabis as Medicine
  • Basics Considerations for Medical Cannabis in a Health Care Setting
  • Introduction & Use of “Eligibility Qualifications Manual” The medical conditions that constitute terminal or debilitating conditions, and the symptoms of those conditions;
  • Short and long-term effects of cannabinoids;
  • Products that may benefit qualifying patients based on the patient’s terminal or debilitating medical condition;
  • Risks and benefits of various routes of cannabis administration
  • Safe handling and storage of useable marijuana, marijuana-infused products, and marijuana concentrates, including strategies to reduce access by minors;
  • Side Effects and Medical Risks Associated with Cannabis Use
  • Cannabis Dosing and Documentation

Community Outreach

With specific print, broadcast and social media and direct personal contact with organizations that specifically serve individuals who have:

  • Amyotrophic Lateral Sclerosis (ALS)
    Cancer
  • Crohn’s disease
  • Fibromyalgia
  • Glaucoma
  • Hepatitis C
  • HIV/AIDS
  • Inflammatory bowel disease
  • Multiple sclerosis
  • Pain (chronic and severe pain or
  • intractable pain)
  • Parkinson’s disease
  • Post-traumatic stress disorder (PTSD)
  • Seizures, including epilepsy
  • Severe and persistent muscle spasms
  • Sickle cell anemia
  • Spinal cord disease or injury
  • Terminal illness
  • Tourette’s syndrome
  • Traumatic brain injury (TBI)
  • Ulcerative colitis

    SOPs

    We can provide training and assistance in revising SOPs in order to stay up to date with the rights of patients qualified and registered to use state-approved medical marijuana.

    Laboratory-based-survey

    for documenting the effects on users of different strains and forms of cannabis and other herbal products. This Comparative Effectiveness Research (CER) is designed to promote informed decisions concerning botanical products by providing outcomes research evidence on their effectiveness, benefits, and harms.
    o Producing and supervision survey process
    o Active promotion of use of survey
    o Processing survey results that document user demographic information and preferences while maintain privacy and —
    o Extraction, analytical characterization and dissemination of the results from these user surveys discovering which botanical products work best— for whom and under what circumstances.

    Patient Informed Consent

    for documenting the effects on users of different strains and forms of cannabis and other herbal products. This Comparative Effectiveness Research (CER) is designed to promote informed decisions concerning botanical products by providing outcomes research evidence on their effectiveness, benefits, and harms.
    o Producing and supervision survey process
    o Active promotion of use of survey
    o Processing survey results that document user demographic information and preferences while maintain privacy and —
    o Extraction, analytical characterization and dissemination of the results from these user surveys discovering which botanical products work best— for whom and under what circumstances.

    Laboratory research

    to establish and document best practices and technologies for the growing and processing of cannabis & other herbal products.

    Working With Government

    at national, state, tribal and levels to create and implement sensible regulations mandating cannabis and other herbal products sold be tested for safety and labeled with meaningful information

    Join us in making evidence-based education & outreach available

    Connect